2990 Hurwitz, Mark - Thomas Jefferson University - Thomas Jefferson University
mdh006

Mark Hurwitz, MD

Contact Dr. Hurwitz

111 South 11th Street
Bodine Cancer Center,
Suite G-301
Philadelphia, PA 19107

(215) 955-6644
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma
  2. High dose rate brachytherapy boost for prostate cancer: A systematic review
  3. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  4. Components of a hyperthermia clinic: Recommendations for staffing, equipment, and treatment monitoring
  5. The quality frontier
  6. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results.
  7. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
  8. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
  9. Evolution of advanced technologies in prostate cancer radiotherapy
  10. Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: Implications for focal therapy
  11. Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation
  12. Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: Long-term results of CALGB 99809
  13. Combined hyperthermia and radiotherapy for the treatment of cancer
  14. Magnetic resonance-guided focused ultrasound surgery for treatment of painful osseous metastases
  15. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer
  16. The crossroads of prostate cancer and thermal medicine
  17. Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer
  18. Today's thermal therapy: Not your father's hyperthermia: Challenges and opportunities in application of hyperthermia for the 21st century cancer patient
  19. Combination External Beam Radiation and Brachytherapy Boost With Androgen Suppression for Treatment of Intermediate-Risk Prostate Cancer: An Initial Report of CALGB 99809
  20. Technology Insight: Combined external-beam radiation therapy and brachytherapy in the management of prostate cancer
0